X-LINKED HYPOPHOSPHATEMIA is the most common inherited cause of rickets (44) . Children with this disorder have marked short stature and rickets. This X-linked dominant disorder is characterized by hypophosphatemia, normocalcemia, and a relative deficiency of 1,25(OH) 2 vitamin D (44). The hypophosphatemia is due to impaired proximal tubule phosphate reabsorption (10, 14, 19, 22, 44, 48) . The vitamin D deficiency is due to decreased 25(OH)D-1␣-hydroxylase activity (11, 13, 40, 45) .
The Hyp mouse has a mutation in the same ortholog as that in patients with X-linked hypophosphatemia (7, 18, 44) . The overwhelming evidence points to a humoral factor mediating the aberrant proximal tubule phosphate transport in this disorder. Parabiosis studies have demonstrated that this humoral factor can impair phosphate transport in normal mice and that the humoral factor is not parathyroid hormone (PTH) (29, 30) . Transplantation of a Hyp mouse kidney into a control mouse leads to normal phosphate levels and rates of phosphate excretion, whereas transplantation of a normal kidney into a Hyp mouse results in hyperphosphaturia (33) . The factor that inhibits proximal tubule transport may be liberated from bone (23, 39) . Both serum from Hyp mice and conditioned media from Hyp mouse primary osteoblastlike cell cultures inhibit mouse proximal tubule phosphate transport (39) . Thus there does not appear to be an intrinsic proximal tubule defect in X-linked hypophosphatemia.
While there is no intrinsic defect in the proximal tubule or the NaPi cotransporter, the V max of the NaPi cotransporter (NaPi-2A) was 50% less than that in control mice (31, 46) . Previous studies have also demonstrated that the decrease in phosphate transport was due, at least in part, to a reduction in NaPi-2A mRNA and brush-border membrane protein abundance compared with control mice (9, 48) . The purpose of the present study was to examine the relative rates of phosphate and volume absorption in proximal tubules from Hyp mice and to determine whether the reduction in phosphate transport was acutely reversible in vitro. The present study provides evidence that the reduction in phosphate transport in Hyp mice is due, at least in part, to posttranscriptional regulation of the NaPi-2A cotransporter.
METHODS
In vitro microperfusion flux studies. Male C57/B6 and Hyp mice were of the same genetic background. They were allowed free access to food and water until the time of the study. This study conformed to the American Physiological Society's Guiding Principles in the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center. Isolated segments of superficial proximal straight tubules (PST) were perfused as previously described (3, 36) . Briefly, tubules were dissected in Hanks' balanced salt solution containing (in mM) 137 NaCl, 5 KCl, 0.8 MgSO 4, 0.33 Na2HPO4, 0.44 KH 2PO4, 1 MgCl2, 10 Tris, 0.25 CaCl2, 2 glutamine, and 2 L-lactate at 4°C. Dissected tubules were then transferred to a 1.2-ml temperature-controlled bath chamber and perfused using concentric glass pipettes at 38°C.
PST were perfused at ϳ10 nl/min. The perfusion solution was an ultrafiltrate-like solution containing (in mM) 115 NaCl, 25 NaHCO 3, 4.0 Na 2HPO4, 10 Na acetate, 1.8 mM CaCl2, 1 MgSO4, 5 KCl, 8.3 glucose, and 5 alanine. The bathing solution contained 6 g/dl BSA. The osmolality of all solutions were adjusted to 295 mosmol/kgH 2O. The pH and osmolality of the bathing solution were maintained constant by continuously changing the bath at a rate of at least 0.5 ml/min. Net volume absorption (J V; in nl⅐ mm Ϫ1 ⅐ min Ϫ1 ) was measured as the difference between the perfusion (V o) and collection (VL) rates (nl/min) normalized per millimeter of tubular length (L). Freshly dialyzed [methoxy-3 H]inulin was added to the perfusate at a concentration of 75 Ci/ml so that the perfusion rate could be calculated. The collection rate was measured with a 50-nl constant-volume pipette. The length (in mm) was measured with an eyepiece micrometer. Tubules were incubated for 15-20 min before initiation of the control period. Phosphate transport was determined using the following equation
where Po is the phosphate concentration in the perfusate, and C * o and C* L are the phosphate concentrations in the perfusate and collected fluids, respectively, in counts per minute per nanoliter.
Brush-border membrane vesicle isolation. C57/B6 and Hyp mouse kidneys were removed and placed in ice-cold isolation buffer containing (in mM) 300 mannitol, 16 HEPES, and 5 EGTA titrated to pH 7.4 with Tris. The isolation buffer contained aprotinin (2 g/ml), leupeptin (2 g/ml), and phenylmethylsulfonyl fluoride (100 g/ml).
The cortex was homogenized with 20 strokes of a Potter Eljevhem homogenizer at 4°C. Brush-border membrane vesicles (BBMV) were then isolated by differential centrifugation and magnesium precipitation as described previously (17) . The final BBMV fraction was resuspended in isolation buffer. Protein was assayed using the Lowry method with crystalline BSA as the standard (26) .
SDS-PAGE and immunoblotting. Brush-border membrane proteins and proteins from the cortical homogenate (25 g/lane) were denatured and then separated on a 7.5% polyacrylamide gel using SDS-PAGE as previously described (4). The proteins were transferred overnight to a polyvinylidiene difluoride membrane at 120 -140 mA at 4°C. The blot was blocked with fresh Blotto (5% nonfat milk and 0.1% Tween 20 in PBS, pH 7.4) for 1 h followed by incubation with primary antibody to NaPi-2A. NaPi-2A antibody, a generous gift from Dr. Jürg Biber (University of Zürich, Zürich, Switzerland), was added at 1:1,000 dilution overnight at 4°C. The blot was then washed extensively with Blotto. The secondary antibody, horseradish peroxidase-conjugated donkey anti-rabbit Ig was added at 1:10,000 dilution and incubated in room temperature for 1 h. The blot was again washed with Blotto, and enhanced chemiluminescence was used to detect bound antibody (Amersham Life Science). The NaPi-2A protein abundance was quantitated using densitometry. Equal loading of the samples was confirmed using an antibody to ␤-actin at a 1:5,000 dilution (Sigma, St. Louis, MO).
In vitro microperfusion and single-tubule immunohistotchemistry. Mouse PST were dissected and perfused as described above with slight modifications. The perfusion and bathing solutions were an ultrafiltrate-like solution, which both contained 2 mM glutamine and lactate. Hyp and C57/B6 mouse tubules were perfused for either 5 min and maintained at 4°C or were heated to 38°C for 60 min. They were then fixed while still being perfused for 5-10 min in the bathing chamber. The fixative consisted of 3% paraformaldehyde and 0.05% Fig. 1 . Proximal tubules from C57/B6 male and Hyp male mice were perfused in vitro. The rate of volume absorption (JV) was similar in C57/B6 male and Hyp male mice proximal straight tubules (A). However, as shown in B, the rate of phosphate absorption (Jphos) was lower in Hyp male mice proximal straight tubules than in those of C57/B6 male mice. *P Ͻ 0.01 Fig. 2 . A: top immunoblot compares NaPi cotransporter NaPi-2A brush-border membrane abundance in C57/B6 male and Hyp male mice. The bottom immunoblot compares total cellular NaPi-2A abundance in C57/B6 male and Hyp male mice. Cont, control. As shown in B, C57/B6 male mice had significantly greater brush-border membrance vesicle (BBMV) NaPi-2A/␤-actin abundance than Hyp mice, whereas there is no difference in C57/B6 male and Hyp mice total cellular NaPi-2A/␤-actin abundance. picric acid, which was dissolved in a 3:2 mixture of 0.1 M cacodylate buffer (pH 7.4, adjusted to 300 mosmol/kgH2O with sucrose) and 10% hydroxyethyl starch in saline (HAES-sterile, Fresenius, Stans, Switzerland) as described by Traebert et al. and our laboratory (2, 51). The tubule was then released near the bottom of the bathing chamber, and the bathing chamber was removed to a dissection microscope for better visualization of the tubule. Immediately before the tubule was transferred, a drop of warm (38°C) 10% gelatin (Gelatin Type A 175 Bloom, Sigma) in PBS was placed on a microscope slide cooled to 4°C. After the gelatin hardened slightly, the tubule was transferred with an Eppendorf pipette from the bathing chamber to the gelatin. The excess fixative was removed from the drop of gelatin, and a second drop of cooled but still molten gelatin was placed on top of the tubule. The slide was placed at 4°C for 1 h, and then a cube of gelatin containing the tubule oriented in the long axis was cut and stored in fixative at 4°C.
For immunodetection of NaPi-2A in single tubules, the gelatin droplets containing the tubules were washed for 2 h in PBS and cut into cubes before being frozen in liquid propane. Cryosections of 2-to 3-m thickness were mounted on chromalum/gelatin-coated glass slides, thawed, and stored in PBS until labeling use. For immunofluorescence, sections were pretreated with 3% milk powder in PBS for 10 min and incubated overnight at 4°C with a rabbit anti-rat polyclonal antiserum against NaPi-2A. For type 3 Na ϩ /H ϩ exchanger (NHE3), we used a polyclonal anti-rat NHE3 antibody diluted 1:300 in 5% milk powder in PBS containing 0.05% Tween 20. Sections were then rinsed three times with PBS and incubated for 45 min at 4°C with the secondary antibody (swine anti-rabbit IgG conjugated to fluorescein isothiocyanate, Dakopatts, Glostrup, Denmark) diluted 1:50 in PBS/milk powder. Finally, the sections were rinsed three times with distilled water, plated on coverslips by using DAKO-Glycergel (Dakopatts) containing 2.5% 1,4-diazabicyclo (2.2.2.) octane (DABCO; Sigma) as a fading retardant, and studied by an epifluorescence microscope (Polyvar, Reichert-Jung). Controls performed with omission of the primary antiserum or with nonimmune sera were all negative.
RESULTS
In the first series of experiments, we compared the rate of volume absorption and phosphate transport in C57/B6 and Hyp mice PST perfused in vitro. The rates of volume absorption in proximal tubules from C57/B6 and Hyp mice were 0.32 Ϯ 0.07 and 0.23 Ϯ 0.06 nl⅐mm Ϫ1 ⅐min Ϫ1 , respectively. This difference was not statistically significant. However, as shown in Fig. 1 , the rate of phosphate transport in C57/B6 male was over twofold greater than that of Hyp male mice. Thus there is reduced phosphate transport in intact Hyp mice tubules perfused in vitro. We next examined whether the reduction in phospate transport was reflected by a reduction in BBMV NaPi-2A cotransporter abundance. The results are shown in Fig. 2 . While BBMV in Hyp mice had significantly less NaPi-2A protein abundance than C57/B6 mice, total cellular NaPi-2A protein abundance was not different between these mice. This result suggested to us that there may be posttranscriptional regulation of the NaPi-2A cotransporter. In the next series of experiments, we examined whether the time of incubation affected the rate of volume and phosphate absorption in C57/B6 and Hyp mice. Proximal tubules from both groups were perfused in vitro at 38°C for 15-20 min, after which determinations were made of phosphate and volume absorption. The tubules were then incubated again for a total of ϳ1 h, and measurements of transport rates were repeated. The rate of volume absorption in proximal tubules from C57/B6 mice was 0.39 Ϯ 0.09 in the first period and 0.35 Ϯ 0.11 nl⅐ mm Ϫ1 ⅐min Ϫ1 in the second period. For in vitro perfused proximal tubules from Hyp mice, the rate of volume absorption was 0.32 Ϯ 0.09 in the first period and 0.27 Ϯ 0.11 nl ⅐ mm Ϫ1 ⅐min Ϫ1 in the second period. Thus the rate of volume absorption did not change significantly in either strain. As shown in Fig. 3 , while the rate of phosphate transport did not change in proximal tubules from C57/B6 mice, there was a significant increase in the rate of phosphate transport with time in the Hyp mouse proximal tubules consistent with phosphatonin washout.
We next examined whether the time-dependent increase in phosphate transport that occurred with time of incubation occurred in the presence of 5 g/ml cycloheximide. This dose of cycloheximide has been shown to inhibit Ͼ95% [ 3 H]leucine incorporation in MCT and NIH cells as well as inhibit the glucocorticoid-induced increase in bicarbonate absorption in rabbit proximal tubules perfused in vitro (6, 53) . As shown in Fig. 4 , there was an increase in the rate of phosphate transport even with cycloheximide in the bathing solution. Thus the proposed phosphatonin washout occurs in the absence of new protein synthesis.
In Fig. 5 , we compared basal NaPi-2A expression in C57/B6 and Hyp mice proximal tubules perfused in vitro. In this experiment proximal tubules were dissected at 4°C, transferred to a microperfusion chamber, and perfused in vitro for 5 min at 4°C. As can be seen, there is a paucity of apical membrane NaPi-2A expression in Hyp mouse proximal tubules, whereas there was intense staining in proximal tubules from C57/B6 mice. Thus C57/B6 proximal tubules had more apical NaPi-2A expression than Hyp mouse tubules as expected from the immunoblot of BBMV from the two strains.
We next examined whether the apical expression of NaPi-2A would mirror the increase in phosphate transport with incubation for 1 h at 38°C. Apical NaPi-2A expression remained intense in C57/B6 mice (Fig. 6) . In Hyp mouse proximal tubules, the staining for NaPi-2A increased after 1 h of incubation, consistent with the increase noted in our phosphate absorption data. This was also true if the bathing solution contained cycloheximide. In the final series of experiments, we examined whether there was an increase in apical NaPi-2A expression in Hyp mouse proximal tubules in the presence of 10 Ϫ4 M luminal and bath colchicine, which disrupts microtubules. As shown in Fig. 7 , the increase in NaPi-2A after 1 h of incubation at 38°C was prevented by colchicine.
DISCUSSION
The present study used in vitro microperfusion of proximal tubules to compare the rates of phosphate transport in Hyp and Fig. 5 . NaPi-2A and NHE3 expression in in vitro perfused proximal straight tubules obtained from Hyp mice and C57/B6 mice. In these studies, tubules were dissected at 4°C, perfused in vitro for 5 min at the same temperature, fixed, and then stained for NaPi-2A or NHE3. As can be seen, there is a paucity of NaPi-2A staining on the brushborder membrane in Hyp mice (A) compared with C57/B6 mice proximal tubules (B). The staining for NHE3 in Hyp mice (C) is comparable to that in C57/B6 mice (D).
C57/B6 mice. We demonstrate that while the rate of total volume absorption was not significantly lower than that in C57/B6 mouse tubules, the rate of phosphate transport in Hyp mice proximal tubules was far lower than that of C57/B6 mouse tubules. These data are consistent with a selective decrease in proximal tubule phosphate transport in these mice.
Previous studies have examined phosphate transport in Hyp mice compared with C57/B6 mice. BBMV from Hyp mice have a lower rate of phosphate transport than those in control mice due to a lower V max of NaP i cotransport (31, 46) . Several studies point to the fact that the phosphate transport defect in the Hyp mouse is not due to an intrinsic abnormality in the Hyp proximal tubule. First, the NaPi-2A cotransporter is not mutated in the Hyp mouse (9) . Furthermore, immortalized proximal tubule cells from Hyp mice have normal rates of phosphate transport when studied days to weeks after removal from the Hyp mouse (32, 34) . The present study demonstrates that while the intrinsic rate of phosphate transport is lower in Hyp proximal tubules, the rate of phosphate transport normalizes rapidly after perfusion in vitro. This effect was not due to a nonspecific effect of in vitro microperfusion since the rate of phosphate transport was stable in proximal tubules from C57/B6 mice.
The fact that Hyp proximal tubules maintain a reduced rate of phosphate transport when perfused in vitro, at least transiently, indicates that the proximal tubule from the Hyp mouse has a memory for its in vivo environment when the tubules are perfused in vitro. This memory effect has been described previously in other in vivo microperfusion studies of both the proximal and distal tubule where the in vivo transport properties are maintained when the tubule is studied in vitro (1, 27, 28, 41) . Hyp mice and patients with X-linked hypophosphatemia have a mutation in the PHEX gene (phosphateregulating gene with endopeptidase activity, which is located on the X chromosome) (12, 16, 38, 49) . One laboratory has demonstrated that FGF-23 is a substrate for PHEX but not the mutant form of FGF-23 produced by patients with autosomal dominant hypophosphatemic rickets (8) . However, others have found that FGF-23 is not a PHEX substrate (15, 24) and that in some way the absence of PHEX results in overexpression of FGF-23 (24) . In addition, there are likely to be other phosphatonins. Most patients with X-linked hypophosphatemia have inappropriately high levels of FGF-23 (20, 52, 55) .
There is also direct evidence that FGF-23 inhibits phosphate transport in vivo and in vitro. Injection of recombinant FGF-23 into mice resulted in a reduction in serum phosphate levels and an increase in urinary excretion of phosphate (42) . FGF-23 did not cause an increase in glucose or amino acid excretion (42) . In addition, implantation of FGF-23-secreting tumor cells into nude mice resulted in the development of hypophosphatemia, hyperphosphaturia, an increase in alkaline phosphatase, and a reduction in 1␣-vitamin D hydroxylase (42) . Similar studies have been performed using mutant FGF-23 proteins found in patients with autosomal dominant hypophosphatemic rickets (43) . However, this group failed to find an effect of recombinant native FGF-23 on phosphate transport in opossum kidney (OK) cells (42) . On the other hand, others have demonstrated a reduction in phosphate transport in OK cells incubated with conditioned media from COS-7 cells that have been transfected with V5-tagged FGF-23 (8) . There is evidence from the crystal structure of the FGF receptor that heparin is necessary for the complete assembly of FGF and the FGF receptor (35, 37) . While one group has found that FGF-23 inhibits phosphate transport in OK cells (8) , a cell line with characteristics of proximal tubule cells, others have not seen an effect of FGF-23 in the absence of 10 g/ml heparin (42, 54) .
The normalization of phospate transport acutely after removal from the in vivo environment is consistent with phosphatonin washout. Previous studies have examined the mechanism for the reduction in phosphate transport in Hyp mice compared with C57/B6 mice and found a reduction in not only BBMV NaPi-2A protein abundance but also mRNA abundance (31, 48) . The finding in the current study demonstrating that total cellular NaPi-2A protein abundance is comparable in Hyp and C57/B6 mice despite the fact that there is a reduction in NaPi-2A mRNA suggests that there may be posttranscriptional regulation of NaPi-2A in Hyp mice. A dissociation of BBMV NaPi-2C protein and NaPi-2C mRNA abundance has previously been found in NaPi-2A Ϫ/Ϫ mice (47).
The finding of a reduction in NaPi-2A mRNA abundance in Hyp mice by others and our findings are consistent with posttranscriptional regulation of NaPi-2A comparable to the regulation of NaPi-2A by PTH (21, 25, 50) . PTH infusion into parathyroidectomized rats can reduce NaPi-2A mRNA abundance in as little as 2 h (21). PTH also affects phosphate transport by regulating NaPi-2A cotransporter trafficking (25, 50) . The circulating phosphatonin in Hyp mice might similarly have an effect on posttranscriptional regulation of the NaPi-2A transporter. The increase in phosphate transport and apical membrane NaPi-2A protein abundance in Hyp mice with time when the tubules are perfused in vitro was still present in the presence of cycloheximide. Thus the acute recovery in phosphate transport in Hyp mice is not dependent on NaPi-2A protein synthesis. The increase in apical membrane NaPi-2A protein abundance in Hyp mice proximal tubules with time when the tubules are perfused in vitro was not seen in the presence of colchicine.
The finding that there is not an intrinsic defect in the proximal tubule cell and the NaPi-2A cotransporter may be therapeutically important for X-linked hypophosphatemia. We have recently found that there is dysregulation of renal prostaglandin metabolism in Hyp mice (5) . Hyp mice treated with indomethacin had a normalization in their rate of phosphate excretion due entirely to a tubular increase in phosphate transport. While the present study demonstrates that there was an increase in phosphate transport, it should be stated that while this increase was dramatic, it did not normalize the rate of phosphate transport to that measured in C57/B6 mice. Studies done in the presence of 10 Ϫ6 M bath indomethacin, however, resulted in a complete normalization in the rate of phosphate transport.
In conclusion, this study readdresses the mechanism for the reduction in phosphate transport in Hyp mice compared with C57/B6 mice. We demonstrate that Hyp proximal tubules perfused in vitro have a reduction in the rate of phosphate transport, which normalizes when the tubules are perfused in vitro. This normalization in the rate of phosphate transport is paralleled by an increase in the expression of the NaPi-2A transporter to the apical membrane. Both the recovery in transport and the increased apical expression were not dependent on new protein synthesis. This study suggests that the acute recovery in phospate transport may be the result of posttranscriptional regulation. 
